Prevention of complications of transpapillary endoscopic interventions

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


This study analyzed the treatment results of 345 patients who underwent planned and emergency transpapillary surgical interventions for various diseases of the biliopancreatoduodenal region. Among these patients, 68.9% were women and 31.1% were men aged 18–92 (mean age, 63.7 ± 4.5) years. The study included patients who used various types of transpapillary endoscopic interventions as a treatment method, such as endoscopic papillo-sphincterotomy (71.9%, including choledocholite extraction in 68.7% of the patients), endoprosthetics of the common bile duct and main pancreatic duct (17.8%), balloon dilatation and bougienage of bile duct strictures (6.2%), mechanical lithotripsy (2%), nasobiliary drainage (1%), endoscopic wirsungotomy (0.8%), and endoscopic papillectomy (0.3%). Variants of the inflow of hepaticoholedochus and Wirsung duct were assessed using magnetic resonance cholangiopancreatography. The active implementation of preventive measures regulated by the global community made it possible to reduce the overall incidence of complications of transpapillary interventions to 13.1% and the rates of postoperative mortality to 1.3% (p < 0.05). The use of these measures led to a significant decrease in the incidence of acute post-manipulation pancreatitis from 10.3% to 4.8%, postoperative bleeding from 8.9% to 5.5%, cholangitis from 2.8% to 0.7%, and a low incidence of retroduodenal perforation in 1.1%. Personalized consideration of the modern recommendations of the global endoscopic communities (Europeans, Americans, and Japanese) when performing endoscopic retrograde cholangiopancreatography, as well as original approaches associated with the determination of the anatomical features of the structure of the Vater papilla with variants of fusion of hepaticocholedochus and Wirsung duct, helped to significantly reduce the overall incidence of complications following transpapillary endoscopic procedures from 22.2% to 13.1%.

Full Text

Restricted Access

About the authors

Aleksey A. Feklyunin

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

Author for correspondence.
ORCID iD: 0000-0003-0024-4825
SPIN-code: 8925-0955

candidate of medical sciences

Russian Federation, Saint Petersburg

Pavel N. Romashchenko

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

ORCID iD: 0000-0001-8918-1730
SPIN-code: 3850-1792

doctor of medical sciences, professor

Russian Federation, Saint Petersburg

Nikolai A. Maistrenko

Military Medical Academy named after S.M. Kirov of the Ministry of Defense of the Russian Federation

ORCID iD: 0000-0002-1405-7660
SPIN-code: 2571-9603

doctor of medical sciences, professor

Russian Federation, Saint Petersburg

Valentin S. Omran

6 Military Hospital of the Russian National Guard Troops

ORCID iD: 0000-0003-4092-3224
SPIN-code: 5089-1695

senior resident

Russian Federation, Novosibirsk


  1. Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70(1):80–88. doi: 10.1016/j.gie.2008.10.039
  2. Rustagi T, Jamidar PA. Endoscopic retrograde cholangio-pancreatography-related adverse events: general overview. Gastrointest Endosc Clin N Am. 2015;25:97–106. doi: 10.1016/j.giec.2014.09.005
  3. Glomsaker T, Hoff G, Kvaloy JT, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013;100(3):373–380. doi: 10.1002/bjs.8992
  4. Ryozawa S, Itoi T, Katanuma A. Japan Gastroenterological Endoscopy Society guidelines for endoscopic sphincterotomy. Digestive Endoscopy. 2018;30(2):149–173. doi: 10.1111/den.13001
  5. Chandrasekhara V, Khashab M, Muthusamy V, et al. Adverse events associated with ERCP. Gastrointest Endoscopy. 2017;85(1): 32–47. doi: 10.1016/j.gie.2016.06.051
  6. Dumonceau J-M, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Endoscopy. 2020;52(2):127–149. doi: 10.1055/a-1075-4080
  7. Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: Avoidance and management. Gastrointest Endosc Clin N Am. 2012;22(3):567–586. doi: 10.1016/j.giec.2012.05.001
  8. Fedorov AG, Davydov SV, Klimov AE. Complications of Endoscopic Transpapillary Interventions, Approaches to Prevention And Treatment. Russian Sklifosovsky Journal of Emergency Medical Care. 2012;3:29–35. (In Russ.)
  9. Dumonceaul J-M, Andriulli A, Elmunzer BJ, et al. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline — updated June 2014. Endoscopy. 2014;46(9):799–815. doi: 10.1055/s-0034-1377875
  10. Romashchenko PN, Feklyunin AA, Maistrenko NA, et al. Transpapillyarnye endoskopicheskie operacii: prediktory oslozhnenij i profilaktika ih razvitiya. Endoscopic Surgery. 2021;27(1):40–48. (In Russ.). doi: 10.17116/endoskop20212701140
  11. Pryadko AS, Maistrenko NA, Romashchenko PN, et al. Endoskopicheskie i punktsionnye metodiki v diagnostike i lechenii khronicheskogo pankreatita. Vestnik neotlozhnoi i vosstanovitel’noi meditsiny. 2013;14(4):493–498. (In Russ.). doi: 10.24884/0042-4625-2015-174-5-22-31
  12. Romashchenko PN, Maistrenko NA, Kuznecov AI, et al. Malignant Obstructive Jaundice: Justification of The Method of Biliary Decompression. Annals of Hpb Surgery. 2020;25(2):124–136. (In Russ.). doi: 10.16931/1995-5464.20202124-136
  13. Vasil’ev AYU, Ratnikov VA. Magnitno-rezonansnaya holangiografiya v diagnostike zabolevanij zhelchevyvodyashchih putej: monografiya. Moscow: Medicina; 2006. 200 p. (In Russ.).
  14. Rebrova OYu. Statisticheskij analiz medicinskih dannyh. Primenenie paketa prikladnyh programm Statistica. Moscow: MediaSfera; 2002. 312 p. (In Russ.).
  15. Mariani A, Giussani A, Di Leo M, et al. Guidewire biliary cannulation does not reduce post-ERCP pancreatitis compared with the contrast injection technique in low-risk and high-risk patients. Gastrointest Endosc. 2012;75(2):339–346. doi: 10.1016/j.gie.2011.09.002
  16. Tse F, Yuan Y, Moayyedi P, et al. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45(8):605–618. doi: 10.1055/s-0032-1326640
  17. Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414–1422. doi: 10.1056/nejmc1205928
  18. Ding X, Chen M, Huang S, et al. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2012;76:1152–1159. doi: 10.1016/j.gie.2012.08.021
  19. Puig I, Calvet X, Baylina M, et al. How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis. PLoS One. 2014;9(3):e92922. doi: 10.1371/journal.pone.0092922
  20. Mazaki T, Mado K, Masuda H, et al. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol. 2014;49(2):343–355. doi: 10.1007/s00535-013-0806-1
  21. Buxbaum J, Yan A, Yeh K, et al. Aggressive hydration with lactated Ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014;12(2):303–307. doi: 10.1016/j.cgh.2013.07.026
  22. Wu BU, Hwang JQ, Gardner TH, et al. Lactated Ringer’s solution reduces systemic inflammation compared with saline in patients with acute pancreatitis. Clin Gastroenterol Hepatol. 2011;9(8): 710–717. doi: 10.1016/j.cgh.2011.04.026
  23. Park DH, Kim MH, Lee SK, et al. Endoscopic sphincterotomy vs. endoscopic papillary balloon dilation for choledocholithiasis in patients with liver cirrhosis and coagulopathy. Gastrointest Endosc. 2004;60(2):180–185. doi: 10.1016/s0016-5107(04)01554-8
  24. Tsujino T, Isayama H, Komatsu Y, et al. Risk factors for pancreatitis in patients with common bile duct stones managed by endoscopic papillary balloon dilation. Am J Gastroenterol. 2005;100(1):38–42. doi: 10.1111/j.1572-0241.2005.40638.x
  25. Cotton PB, Connor P, Rawls E, et al. Infection after ERCP and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. Gastrointest Endosc. 2008;67(3):471–475. doi: 10.1016/j.gie.2007.06.065
  26. Bangarulingam SY, Gossard AA, Petersen BT, et al. Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis. Am J Gastroenterol. 2009;104(4):855–860. doi: 10.1038/ajg.2008.161
  27. Sawas T, Al Halabi S, Parsi MA, et al. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82(2):256–267. doi: 10.1016/j.gie.2015.03.1980
  28. Costamagna G, Boskoski I. Current treatment of benign biliary strictures. Ann Gastroenterol. 2013;26(1):37–40. doi: 10.1016/b978-0-323-48109-0.00043-2

Copyright (c) 2021 Feklyunin A.A., Romashchenko P.N., Maistrenko N.A., Omran V.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies